Agitation

AUG 19, 2026 · PHASE 3 TRIAL

A Study to Evaluate the Long-term Efficacy and Safety of KarXT + KarX-EC for Agitation in Alzheimer's Disease (ADAGIO-3)

ClinicalTrials.gov

This is an active Phase 3 trial registration with no results posted; it describes a planned long-term extension study in a defined population but carries no efficacy or safety data yet.

AUG 13, 2026 · PHASE 2 TRIAL

Study to Evaluate the Efficacy, Safety, and Tolerability of BMS-986368, for the Treatment of Agitation in Participants With Alzheimer's Disease

ClinicalTrials.gov

This is a Phase 2 trial registration with no reported results; enrollment is ongoing and efficacy data are not yet available.

AUG 13, 2026 · PHASE 3 TRIAL

A Study to Assess the Efficacy and Safety of AXS-05 in Subjects With Alzheimer's Disease Agitation

ClinicalTrials.gov

Phase 3 RCT with completed enrollment and defined primary endpoint, but no results posted in this registry record; the design is sound but outcomes remain unreported.